XIN-5494

N/A

Report date: 2023/07/07 18:22:27
NME

Base Information

Drug NameXIN-5494
Drug Alias NameXIN-5494
ClassificationSmall molecules
Mechanisms of ActionMAP kinase-interacting serine/threonine-protein kinase 2 inhibitors
TargetsMAP kinase-interacting serine/threonine-protein kinase 2
Therapy Area/IndicationsAutoimmune DiseasesArthritis, RheumatoidSpondylitis, Ankylosing +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXinThera Inc
China Registration ClassN/A

Develop Information

Active CompaniesXinThera Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesArthritis, RheumatoidSpondylitis, Ankylosing +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A